China Sprints Ahead Of India In Innovation Efforts, Says McKinsey Executive: Will The Gap Get Wider?
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - China has far outpaced India on the innovation front even though the two Asian giants were at almost the same level barely 10 years ago, with China's rush ahead due to strong government initiatives on healthcare reforms and a constant flow of professionals with experience at Western global pharmaceutical companies returning to the motherland
You may also be interested in...
Rising Scientific Powers India And China Compete For Bigger Shares Of Expanding Market In R&D Outsourcing
BEIJING - Global pharmaceutical players are likely to step up the transfer of research to specialist firms across China and India over the next decade, as the Asian giants continue to evolve into major scientific powers
Rising Scientific Powers India And China Compete For Bigger Shares Of Expanding Market In R&D Outsourcing
BEIJING - Global pharmaceutical players are likely to step up the transfer of research to specialist firms across China and India over the next decade, as the Asian giants continue to evolve into major scientific powers
India’s Jubilant, Eli Lilly In Joint Venture To Develop Molecules
Jubilant Organosys of India and Eli Lilly created a joint venture to develop molecules to develop a variety of treatments, including cancer and diabetes. The evenly divided research and development venture intends to develop molecules through the Phase II stage as well as develop molecules for other pharmaceutical companies. The new company is to be based in India and begin operating before the end of the year, with the parent companies investing a combined $8 million over the next three years. (Click here for more